University of California Los Angeles, Nuclear Medicine Clinic — Los Angeles, California

University of California Los Angeles, Nuclear Medicine Clinic is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of California Los Angeles, Nuclear Medicine Clinic has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer.

Sponsors: POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California Los Angeles, Nuclear Medicine Clinic?

University of California Los Angeles, Nuclear Medicine Clinic has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California Los Angeles, Nuclear Medicine Clinic conducted?

University of California Los Angeles, Nuclear Medicine Clinic has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer.

Is University of California Los Angeles, Nuclear Medicine Clinic accredited by Crixeo Health?

University of California Los Angeles, Nuclear Medicine Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California Los Angeles, Nuclear Medicine Clinic?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.